Recombinant Human Antibody prepared by a genetic engineering technique which specifically reacts with V. vulnificus, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-V. vulnificus mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-V. vulnificus mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.